Who is sponsoring NCT05969353?

NCT05969353 is sponsored by Bnai Zion Medical Center.

What drugs are being tested in NCT05969353?

Interventions in NCT05969353: accupunture.

Is NCT05969353 still recruiting?

NCT05969353 is currently status unknown. Last updated 1 August 2023.

Last reviewed 2023-08-01 · How we verify

NCT05969353

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Assessing the Effectiveness of BFA as a Non-pharmacologic Pain Management Intervention: A Randomised Sham Controlled Study

Status unknown NA Last updated 1 August 2023

What this trial tests

NA trial testing accupunture in Assessing the Effectiveness of BFA as a Non-pharmacologic Pain Management Intervention: A Randomised Sham Controlled Study in 200 participants. Status unknown.

Timeline

23 July 2023

Primary endpoint
30 December 2025

10 January 2026

Quick facts

Lead sponsor	Bnai Zion Medical Center
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	supportive care
Enrollment	200
Start date	23 July 2023
Primary completion	30 December 2025
Estimated completion	10 January 2026
Sites	1 location across Israel

Drugs / interventions tested

accupunture

Conditions studied

Assessing the Effectiveness of BFA as a Non-pharmacologic Pain Management Intervention: A Randomised Sham Controlled Study — all drugs for Assessing the Effectiveness of BFA as a Non-pharmacologic Pain Management Intervention: A Randomised Sham Controlled Study →

Sponsor

Bnai Zion Medical Center

Who can join

18 and older, any sex, with Assessing the Effectiveness of BFA as a Non-pharmacologic Pain Management Intervention: A Randomised Sham Controlled Study. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This is a randomized sham controlled study that will include patients hospitalized in the internal medicine department and the orthopedics department at Bnei Zion Hospital presenting with pain from various sources with an NRS level equal to or above 4.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Bnai Zion Medical Center trials

Trials by the same sponsor.

NCT07323901 — GRAPE-GDM Prospective Comperative Trial - Grape Juice as a Replacement Drink for Gestational Diabetes Screening · NA · enrolling by invitation
NCT06487169 — Effectivity Gas Extraction to Prevent Anesthesiologists Waste Gas Exposure of Sevofluorane During Pediatric Induction · not yet recruiting
NCT06581185 — Pseudotumor Cerebri Headache Ten Years Outcome · enrolling by invitation
NCT07288021 — Topical Anesthesia During Catheter Insertion for Cervical Ripening (TOLERANCE) · Phase 4 · recruiting
NCT06190964 — Integrative Medicine for Hospital Workers Exposed to War · NA · unknown

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05969353 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Bnai Zion Medical Center
Last refreshed: 1 August 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05969353.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing